Ampio Pharmaceuticals, Inc. (OTCPK: AMPE)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Ampio Pharmaceuticals, Inc. (OTCPK: AMPE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $207.88K and employs 6 people.
trading between 0.00 and 0.64.
Tweenvest scores Ampio Pharmaceuticals, Inc. across four factors: quality 44/100, value 66/100. Its strongest factor is value.
AMPE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $207.88K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -10.66
- Dividend yield
- —
- Beta (5Y)
- 17.51
- 52-week high
- $0.64
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.14M
- Employees
- 6
- Next earnings
- —
About Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc., headquartered in Englewood, Colorado, is a biopharmaceutical firm dedicated to advancing immunomodulatory therapeutics primarily for the management of osteoarthritis pain across the United States. Their developmental pipeline currently features several compounds: AP-013, an intra-articular injection, is undergoing Phase III clinical trials for knee osteoarthritis. Additionally, the company has multiple candidates addressing COVID-19: AP-017, an intravenous Ampion formulation, is in Phase II for adult COVID-19 patients who require supplemental oxygen; AP-019, an inhaled Ampion treatment, also in Phase II, targets adults experiencing respiratory distress from COVID-19; while AP-018, currently in Phase I, aims to treat individuals with persistent respiratory symptoms following COVID-19 infection.
- ISIN
- US03209T3077
- Listed since
- Mar 31, 2010
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lyra Therapeutics, Inc.OTCPK: LYRA | $266.23K | $0.15 | -25.00% |
| Wesana Health Holdings Inc.CNSX: WESA.X | $251.48K | CA$— | — |
| Cresanto Global LimitedBSE: 531207 | $239.54K | Rs5.37 | — |
| Grapefruit USA, Inc.OTCPK: GPFT | $226.66K | $0.00 | -50.00% |
| Virpax Pharmaceuticals, Inc.OTCPK: VRPX | $192.59K | $0.16 | +15499900.00% |
| CNBX Pharmaceuticals Inc.OTCPK: CNBX | $192.58K | $0.00 | -4.76% |
| GNCC Capital, Inc.OTCPK: GNCP | $174.15K | $0.00 | -99.00% |
| NanoSphere Health Sciences Inc.CNSX: NSHS.X | $147.66K | CA$— | — |
Figures last refreshed Oct 4, 2026.